Eagle Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Eagle Pharmaceuticals

09/11/2021 14:32

* Eagle Pharmaceuticals Inc  EGRX.OQ  reported quarterly
adjusted earnings of 56 cents​​ per share for the quarter ended
in September. The mean expectation of three analysts for the
quarter was for earnings of 83 cents per share.
* Revenue fell 20.2% to $39.85 million from a year ago; 
analysts expected $46.40 million. 
* Eagle Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 43 cents​.
* The mean earnings estimate of analysts had fallen by
about 8.2% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Eagle Pharmaceuticals Inc shares had fallen by 8.4% this
quarter and gained 9.7% so far this year.
* The company reported a quarterly loss of $5.62 million.
* Wall Street's median 12-month price target for Eagle
Pharmaceuticals Inc is $48.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 9 at 02:31 p.m.
 ​All figures in US dollars unless otherwise stated